Chennai Meenakshi Multispeciality Hospital director tenure ends

Chennai Meenakshi Multispeciality Hospital Limited announced that Independent Director Nagayasamy Rajkumar ceased to hold office effective the close of business hours on June 8, 2026, following the completion of his five-year tenure. This cessation was disclosed to the stock exchange under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

As a result of stepping down from the board, Mr. Nagayasamy Rajkumar automatically ceased to be the Chairperson and Member of the Audit, Stakeholder's, and Nomination and Remuneration Committees. The company confirmed that the change was due solely to the completion of the stipulated tenure period.

Regulatory Disclosures

The filing referenced specific regulatory guidelines, including SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The detailed disclosure regarding the director's exit was submitted as Annexure-A to the exchange.

Details of Cessation

The following table outlines the key details regarding the change in directorship:

S. No.	Particulars	Details
(i)	Reason for change	Cessation due to completion of the 5-year tenure as an Independent Director of the Company.
(ii)	Date of Resignation	Close of business hours on June 8, 2026.
(iii)	Brief Profile	Not Applicable
(iv)	Disclosure of relationship between directors	Not Applicable
(v)	Letter of resignation along with detailed reason	Not Applicable

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-5.40%	+5.83%	+0.25%	-13.82%	+19.21%	+216.80%

Chennai Meenakshi Multispeciality Hospital Limited has reported a total income of ₹3815.66 lakh for the year ended March 31, 2026, an increase from ₹3567.21 lakh in the previous year. The hospital narrowed its net loss to ₹111.72 lakh for the fiscal year, compared to a net loss of ₹137.37 lakh in FY25. Revenue from operations for FY26 stood at ₹3703.90 lakh, up from ₹3481.85 lakh in the prior year.

For the quarter ended March 31, 2026, the company recorded a total income of ₹1004.96 lakh and a net loss of ₹2.13 lakh. The board of directors approved the audited financial results at a meeting held on May 25, 2026. The statutory auditors, M/s. Elias George & Co., issued an audit report with an unmodified opinion on the standalone financial results.

Financial Performance

The hospital's expenses for the full year totaled ₹3930.34 lakh, a slight increase from ₹3710.02 lakh in the previous year. Key expense components included purchases of stock-in-trade at ₹750.05 lakh and employee benefits expenses amounting to ₹972.20 lakh. Finance costs for the year were ₹89.81 lakh, while depreciation and amortisation expenses stood at ₹109.08 lakh.

Key Metrics

Particulars	Year Ended 31.03.2026 (₹ in lakhs)	Year Ended 31.03.2025 (₹ in lakhs)
Revenue from Operations	3703.90	3481.85
Total Income	3815.66	3567.21
Total Expenses	3930.34	3710.02
Net Profit/(Loss)	(111.72)	(137.37)
Basic EPS (Rs.)	(1.50)	(1.84)

Assets and Liabilities

As of March 31, 2026, the company's total assets were valued at ₹2124.09 lakh, a decrease from ₹2250.64 lakh in the previous year. Non-current assets included property, plant, and equipment amounting to ₹1277.39 lakh. The equity and liabilities section showed a negative equity of ₹307.54 lakh, compared to a negative equity of ₹188.73 lakh in the prior year. Non-current liabilities stood at ₹1208.98 lakh, while current liabilities were ₹1222.65 lakh.